Difficulty: Medium
Average Score: 62%
Practice
A47-year-old man presented to the clinic complaining of a recent onset of repeating episodes of vertigo associated with nausea and vomiting. The patient was otherwise healthy and denied use of alcohol or illicit drugs. Physical examination was unremarkable, but a provocative test elicited severe vertigo. A diagnosis was made, and a pharmacotherapy was prescribed. Which of the following drugs would be appropriate for this patient?
Correct answer
A
Rationale
In the case of a 47-year-old man presenting with vertigo, nausea, and vomiting without any significant medical history, the most appropriate pharmacological treatment would be Diphenhydramine (Option A). Diphenhydramine is a first-generation antihistamine with antiemetic properties that can help alleviate symptoms of vertigo and associated nausea. It works by blocking histamine receptors in the brain, reducing the sensation of motion that can trigger vertigo.
Option B, Ondansetron, is primarily used for nausea and vomiting associated with chemotherapy or post-operative recovery and may not be as effective for vertigo of non-specific etiology.
Option C, Dronabinol, is a synthetic form of THC used for chemotherapy-induced nausea and vomiting and anorexia in AIDS patients. It is not a first-line treatment for vertigo.
Option D, Ergotamine, is used for migraine headaches and not indicated for the treatment of vertigo symptoms.
Educationally, understanding the rationale behind choosing Diphenhydramine in this scenario highlights the importance of pharmacological specificity in treating symptoms based on their underlying mechanisms. It also underscores the need for a thorough patient history and differential diagnosis to tailor treatment appropriately.
Option B, Ondansetron, is primarily used for nausea and vomiting associated with chemotherapy or post-operative recovery and may not be as effective for vertigo of non-specific etiology.
Option C, Dronabinol, is a synthetic form of THC used for chemotherapy-induced nausea and vomiting and anorexia in AIDS patients. It is not a first-line treatment for vertigo.
Option D, Ergotamine, is used for migraine headaches and not indicated for the treatment of vertigo symptoms.
Educationally, understanding the rationale behind choosing Diphenhydramine in this scenario highlights the importance of pharmacological specificity in treating symptoms based on their underlying mechanisms. It also underscores the need for a thorough patient history and differential diagnosis to tailor treatment appropriately.